The invention concerns animal models of ligand activated HER2-expressing tumors. This model is useful for evaluating the efficacy of various therapeutic approaches for the treatment of such tumors.

 
Web www.patentalert.com

< Transgenic mice containing lymphoid-specific GPCR gene disruptions

< Symphoricarpos plant named 'Brain De Soleil'

> CHRYSANTHEMUM PLANT NAMED 'GEDI THREE CAMAN'

> TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf GENE 1
~ 00285